Sp1047
AGA GUIDELINE Q&A: BIOMARKERS FOR MONITORING INFLAMMATION IN IBD
Date
May 9, 2023
Explore related products in the following collection:
Tracks
Related Products
ANTI-TNF IN COMBINATION WITH LOW DOSE METHOTREXATE OUTPERFORMS ANTI-TNF MONOTHERAPY IN PATIENTS WITH PEDIATRIC CROHN'S DISEASE INITIATING ADALIMUMAB BUT NOT INFLIXIMAB
BACKGROUND: Tumor necrosis factor inhibitors (TNFi) are a mainstay of pediatric Crohn’s disease (PCD) therapy; yet not all patients respond, and others lose response over time. Combination therapy with methotrexate may improve response; however, this has not been rigorously evaluated…
PANEL DISCUSSION
In the last five years, there have been three distinct small molecules that have been approved for the management of ulcerative colitis…
EMPIRIC DIETARY INFLAMMATORY PATTERN (EDIP) IS INVERSELY ASSOCIATED WITH RISK OF MICROSCOPIC COLITIS
BACKGROUND The gut microbiome is central to Crohn’s disease (CD) pathogenesis but the relative contribution of different environmental factors to disease compositional variation is unknown…